Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126623231 | 12662323 | 1 | I | 2015 | 20160729 | 20160817 | 20160817 | PER | US-ASTRAZENECA-2016SE82815 | ASTRAZENECA | 73.00 | YR | M | Y | 79.40000 | KG | 20160817 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126623231 | 12662323 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 80/4.5 MCG | 21929 | ||||||||||
| 126623231 | 12662323 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 80/4.5 MCG | 21929 | ||||||||||
| 126623231 | 12662323 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS TWICE A DAY | 21929 | ||||||||||
| 126623231 | 12662323 | 4 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS TWICE A DAY | 21929 | ||||||||||
| 126623231 | 12662323 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | UNKNOWN | 0 | 10 | MG | QD | |||||||
| 126623231 | 12662323 | 6 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | Oral | 88, DAILY | UNKNOWN | 0 | |||||||||
| 126623231 | 12662323 | 7 | C | VITAMINS | VITAMINS | 1 | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126623231 | 12662323 | 1 | Emphysema |
| 126623231 | 12662323 | 2 | Asthma |
| 126623231 | 12662323 | 3 | Emphysema |
| 126623231 | 12662323 | 4 | Asthma |
| 126623231 | 12662323 | 5 | Blood cholesterol abnormal |
| 126623231 | 12662323 | 6 | Thyroid disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126623231 | 12662323 | Dyspnoea | |
| 126623231 | 12662323 | Emphysema | |
| 126623231 | 12662323 | Hypoaesthesia | |
| 126623231 | 12662323 | Oropharyngeal discomfort | |
| 126623231 | 12662323 | Thyroid disorder | |
| 126623231 | 12662323 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126623231 | 12662323 | 3 | 2015 | 0 | ||
| 126623231 | 12662323 | 4 | 2015 | 0 | ||
| 126623231 | 12662323 | 5 | 2011 | 0 | ||
| 126623231 | 12662323 | 6 | 2016 | 0 |